| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2967167 | Journal of Clinical Lipidology | 2009 | 10 Pages |
Abstract
Compared to atorvastatin, NER/S provided superior improvements in HDL-C, TG, and Lp(a) and comparable improvements in non-HDL-C and LDL-C. Treatment with NER/S should be considered for patients with dyslipidemia requiring comprehensive lipid control.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
William MD, Jan N. MD, Anthony N. MD, Ping MS, Roopal MD, Robert J. MD,